[1] EL AF, MAHMOUD MF, et al. Effect of Cordyceps sinensis and taurine either alone or in combination on streptozotocin induced diabetes[J]. Food Chem Toxicol. 2012, 50(3-4): 1159-1165.[2] SHIN S, MOON S, PARK Y, et al. Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages via Induced Anti-inflammatory Cytokines[J]. Immune Netw. 2009, 9(6): 255-264.[3] SHRESTHA B, HAN SK, SUNG JM, et al. Fruiting Body Formation of Cordyceps militaris from Multi-Ascospore Isolates and Their Single Ascospore Progeny Strains[J]. Mycobiology. 2012, 40(2): 100-106.[4] ZHENG Z, JIANG K, HUANG C, et al. Cordyceps militaris (Hypocreales: Cordycipitaceae): transcriptional analysis and molecular characterization of cox1 and group I intron with putative LAGLIDADG endonuclease[J]. World J Microbiol Biotechnol. 2012, 28(1): 371-380.[5] CUI JD, ZHANG BZ. Comparison of culture methods on exopolysaccharide production in the submerged culture of Cordyceps militaris and process optimization[J]. Lett Appl Microbiol. 2011, 52(2): 123-128.[6] CHOI JN, KIM J, LEE MY, et al. Metabolomics revealed novel soflavones and optimal cultivation time of Cordyceps militaris fermentation[J]. J Agric Food Chem. 2010, 58(7): 4258-4267.[7] GUO WL, ZHANG ZY, LU JH, et al. [Application of near infrared spectroscopy in screening Cordyceps militaris mutation strains and optimizing their fermentation process] [J]. Guang Pu Xue Yu Guang Pu Fen Xi. 2010, 30(8): 2077-2082. Chinese.[8] CHATZIGEORGIOU A, HAROKOPOS V, MYLONA-KARAGIANNI C, et al. The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time[J]. Ann Med. 2010, 42(6): 426-438.[9] LIN MS, TSE HM, DELMASTRO MM, et al. A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice[J]. Immunol Res. 2011, 50(2-3): 213-220.[10] CSORBA TR, LYON AW, HOLLENBERG MD. Autoimmunity and the pathogenesis of type 1 diabetes[J]. Crit Rev Clin Lab Sci. 2010, 47(2):51-71.[11] HEDMAN M, FARESJ? M, AXELSSON S, et al. Impaired CD4 and CD8 T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children[J]. Clin Exp Immunol. 2008, 153(3): 360-368.[12] SUAREZ-PINZON WL, RABINOVITCH A. Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits[J]. Int J Exp Diabetes Res. 2001, 2(1): 3-17.[13] SEDER, R.A, W.E. PAUL. Acquisition of lymphokine-producing phenotype by CD4+ T cells[J]. Annu. Rev. Immunol. 1994, 12: 635-673.[14] JAHROMI MM, MILLWARD BA, DEMAINE AG. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus[J]. J Interferon Cytokine Res. 2000, 20(10): 885-888.[15] HWANG KW, WON TJ, KIM H, et al . Characterization of the regulatory roles of the SUMO[J]. Diabetes Metab Res Rev. 2011, 27(8): 854-861. [16] CHATZIGEORGIOU A, HAROKOPOS V, MYLONA-KARAGIANNI C, et al. Aidinis V, Kamper EF. The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time[J]. Ann Med. 2010, 42(6): 426-438.[17] CHOI SE, CHOI KM, YOON IH, et al. IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo[J]. Transpl Immunol. 2004, 13(1): 43-53.[18] DIEHL S, RINCON M. The two faces of IL-6 on Th1/Th2 differentiation[J]. Mol Immunol. 2002, 39(9): 531-536.[19] DIEHL S, CHOW CW, WEISS L, et al. Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation[J]. J Exp Med. 2002, 196(1): 39-49.[20] NAKAMURA K, YAMAGUCHI Y, KAGOTA S, et al. Activation of in vivo Kupffer cell function by oral administration of Cordyceps sinensis in rats[J]. Jpn J Pharmacol. 1999, 79(4): 505-508.[21] ZHANG W, YANG J, CHEN J, et al. Immunomodulatory and antitumor effects of exopolysaccharide fraction (EPSF) from a cultivated Cordyceps sinensis fungus on tumor-bearing mice[J]. Biotechnol Appl Biochem. 2005, 42(1): 9-15.[22] XU RH, PENG XE, CHEN GZ, et al. Effects of cordyceps sinensis on natural killer activity and colony formation of B16 melanoma[J]. Chin Med J (Engl). 1992, 105(2): 97-101.[23] YAMAGUCHI N, YOSHIDA J, REN LJ, et al. Augmentation of various immune reactivities of tumor-bearing hosts with an extract of Cordyceps sinensis[J]. Biotherapy. 1990, 2(2): 199-205.[24] KUO YC, TSAI WJ, SHIAO MS, et al. Cordyceps sinensis as an immunomodulatory agent[J]. Am J Chin Med. 1996, 24(2): 111-125.[25] CHEN JR, YEN JH, LIN CC, et al. The effects of Chinese herbs on improving survival and inhibiting anti-ds DNA antibody production in lupus mice[J]. Am J Chin Med. 1993, 21(3): 257-262.[26] ZHANG Z, XIA SS. Cordyceps Sinensis-I as an immunosuppressant in heterotopic heart allograft model in rats[J]. J Tongji Med Univ. 1990, 10(2): 100-103.[27] KIHO T, YAMANE A, HUI J, et al. Polysaccharides in fungi. XXXVI. Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver[J]. Biol Pharm Bull. 1996, 19(3): 294-296. |